Product Images Sodium Phenylacetate And Sodium Benzoate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Sodium Phenylacetate And Sodium Benzoate NDC 81665-204 by Omnivium Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - ammonul 01

Chemical Structure - ammonul 01

Figure 2 - ammonul 02

Figure 2 - ammonul 02

This text appears to be a list of biochemical compounds including alpha-ketoglutarate, benzoate, glutamate, glutamine, phenylacetate, and phenylacetylglutamine. It seems to be a partial description related to biochemistry or metabolic pathways.*

PRINCIPAL DISPLAY PANEL - 50 mL Vial Carton - ammonul 04

PRINCIPAL DISPLAY PANEL - 50 mL Vial Carton - ammonul 04

This text appears to be a description of a pharmaceutical product labeled as Sodium Phenylacetate and Sodium Benzoate Injection, 10%/10%, intended for intravenous use only. The product is provided in a single-dose vial and must be diluted before administration. Each mL contains 100 mg of sodium phenylacetate and 100 mg of sodium benzoate. The storage instructions mention keeping the product at 25°C (77°F) and allowing excursions between 15°C - 30°C. It is distributed by Omnivium Pharmaceuticals and includes a warning to administer it only through a peripheral IV. The text also states that the solution must be diluted with sterile, dextrose injection, 10% (D10W) before intravenous administration.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.